These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16935971)
1. Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer. Linder N; Haglund C; Lundin M; Nordling S; Ristimäki A; Kokkola A; Mrena J; Wiksten JP; Lundin J J Clin Pathol; 2006 Sep; 59(9):965-71. PubMed ID: 16935971 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Linder N; Lundin J; Isola J; Lundin M; Raivio KO; Joensuu H Clin Cancer Res; 2005 Jun; 11(12):4372-81. PubMed ID: 15958620 [TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016 [TBL] [Abstract][Full Text] [Related]
4. Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma. Linder N; Bützow R; Lassus H; Lundin M; Lundin J Gynecol Oncol; 2012 Feb; 124(2):311-8. PubMed ID: 22044687 [TBL] [Abstract][Full Text] [Related]
5. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. Mrena J; Wiksten JP; Nordling S; Kokkola A; Ristimäki A; Haglund C J Clin Pathol; 2006 Jun; 59(6):618-23. PubMed ID: 16731602 [TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
7. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
8. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
10. Loss expression of PHLPP1 correlates with lymph node metastasis and exhibits a poor prognosis in patients with gastric cancer. Wang Z; Shu H; Wang Z; Li G; Cui J; Wu H; Cai S; He W; He Y; Zhan W J Surg Oncol; 2013 Dec; 108(7):427-32. PubMed ID: 24037758 [TBL] [Abstract][Full Text] [Related]
11. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma. Zhao P; Lu Y; Liu L Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Joo YE; Oh WT; Rew JS; Park CS; Choi SK; Kim SJ Digestion; 2002; 66(4):222-9. PubMed ID: 12592098 [TBL] [Abstract][Full Text] [Related]
13. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
14. Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study. Anagnostopoulos GK; Stefanou D; Arkoumani E; Chalkley L; Karagiannis J; Paraskeva K; Mathou N; Dellaporta E; Tsianos E; Agnantis NJ Acta Gastroenterol Belg; 2007; 70(3):285-9. PubMed ID: 18074738 [TBL] [Abstract][Full Text] [Related]
15. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma. Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N Br J Cancer; 1999 Oct; 81(3):484-9. PubMed ID: 10507774 [TBL] [Abstract][Full Text] [Related]
16. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
18. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer. Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539 [TBL] [Abstract][Full Text] [Related]
19. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189 [TBL] [Abstract][Full Text] [Related]
20. [GRP78 expression in gastric cancer and its clinical significance]. Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]